These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 29853653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention.
    Meier SR, Sehlin D, Roshanbin S, Falk VL, Saito T, Saido TC, Neumann U, Rokka J, Eriksson J, Syvänen S.
    J Nucl Med; 2022 Feb; 63(2):302-309. PubMed ID: 34088777
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U, Rueeger H, Machauer R, Veenstra SJ, Lueoend RM, Tintelnot-Blomley M, Laue G, Beltz K, Vogg B, Schmid P, Frieauff W, Shimshek DR, Staufenbiel M, Jacobson LH.
    Mol Neurodegener; 2015 Sep 03; 10():44. PubMed ID: 26336937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody engagement with amyloid-beta does not inhibit [11C]PiB binding for PET imaging.
    Xiong M, Dahlén A, Roshanbin S, Wik E, Aguilar X, Eriksson J, Sehlin D, Syvänen S.
    J Neurochem; 2024 Sep 03; 168(9):2601-2610. PubMed ID: 38721627
    [Abstract] [Full Text] [Related]

  • 7. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
    Fang XT, Hultqvist G, Meier SR, Antoni G, Sehlin D, Syvänen S.
    Neuroimage; 2019 Jan 01; 184():881-888. PubMed ID: 30300753
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
    Deleye S, Waldron AM, Verhaeghe J, Bottelbergs A, Wyffels L, Van Broeck B, Langlois X, Schmidt M, Stroobants S, Staelens S.
    J Nucl Med; 2017 Dec 01; 58(12):1977-1983. PubMed ID: 28611242
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease.
    Gustavsson T, Metzendorf NG, Wik E, Roshanbin S, Julku U, Chourlia A, Nilsson P, Andersson KG, Laudon H, Hultqvist G, Syvänen S, Sehlin D.
    Alzheimers Res Ther; 2023 May 02; 15(1):90. PubMed ID: 37131196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice.
    Rofo F, Meier SR, Metzendorf NG, Morrison JI, Petrovic A, Syvänen S, Sehlin D, Hultqvist G.
    Neurotherapeutics; 2022 Sep 02; 19(5):1588-1602. PubMed ID: 35939261
    [Abstract] [Full Text] [Related]

  • 13. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion.
    Pagnon de la Vega M, Syvänen S, Giedraitis V, Hooley M, Konstantinidis E, Meier SR, Rokka J, Eriksson J, Aguilar X, Spires-Jones TL, Lannfelt L, Nilsson LNG, Erlandsson A, Hultqvist G, Ingelsson M, Sehlin D.
    Acta Neuropathol Commun; 2024 Feb 05; 12(1):22. PubMed ID: 38317196
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation.
    Brendel M, Jaworska A, Overhoff F, Blume T, Probst F, Gildehaus FJ, Bartenstein P, Haass C, Bohrmann B, Herms J, Willem M, Rominger A.
    Theranostics; 2018 Feb 05; 8(18):4957-4968. PubMed ID: 30429879
    [Abstract] [Full Text] [Related]

  • 15. Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging.
    Gustavsson T, Herth MM, Sehlin D, Syvänen S.
    Ups J Med Sci; 2024 Feb 05; 129():. PubMed ID: 38863725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice.
    Jacobsen H, Ozmen L, Caruso A, Narquizian R, Hilpert H, Jacobsen B, Terwel D, Tanghe A, Bohrmann B.
    J Neurosci; 2014 Aug 27; 34(35):11621-30. PubMed ID: 25164658
    [Abstract] [Full Text] [Related]

  • 19. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, Onoe H.
    J Nucl Med; 2016 Feb 27; 57(2):291-6. PubMed ID: 26585055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.